Total Payments
$29,722
2024 Payments
$12,429
Companies
6
Transactions
51
Medicare Patients
180
Medicare Billing
$16,703
Payment Breakdown by Category
Consulting$18,515 (62.3%)
Travel$5,201 (17.5%)
Other$3,335 (11.2%)
Research$1,400 (4.7%)
Food & Beverage$1,271 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,515 | 4 | 62.3% |
| Travel and Lodging | $5,201 | 21 | 17.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,335 | 3 | 11.2% |
| Unspecified | $1,400 | 1 | 4.7% |
| Food and Beverage | $1,271 | 22 | 4.3% |
Payments by Type
General
$28,322
50 transactions
Research
$1,400
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sarepta Therapeutics, Inc. | $13,497 | 19 | $0 (2024) |
| PTC Therapeutics, Inc. | $8,779 | 20 | $0 (2019) |
| PFIZER INC. | $5,524 | 5 | $0 (2020) |
| Biogen, Inc. | $1,697 | 4 | $0 (2022) |
| Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | $135.00 | 2 | $0 (2021) |
| Marathon Pharmaceuticals, LLC | $90.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,429 | 13 | Sarepta Therapeutics, Inc. ($12,429) |
| 2022 | $282.61 | 3 | Biogen, Inc. ($207.61) |
| 2021 | $184.49 | 3 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) ($135.00) |
| 2020 | $2,840 | 2 | Biogen, Inc. ($1,440) |
| 2019 | $7,313 | 15 | PFIZER INC. ($4,124) |
| 2018 | $1,010 | 6 | Sarepta Therapeutics, Inc. ($992.75) |
| 2017 | $5,663 | 9 | PTC Therapeutics, Inc. ($5,572) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/10/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Consulting Fee | Cash or cash equivalent | $10,975.00 | General |
| Category: Genetic Disease | ||||||
| 07/10/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Travel and Lodging | In-kind items and services | $36.00 | General |
| Category: Genetic Disease | ||||||
| 07/10/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: Genetic Disease | ||||||
| 07/10/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Travel and Lodging | In-kind items and services | $9.25 | General |
| Category: Genetic Disease | ||||||
| 07/10/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Travel and Lodging | In-kind items and services | $146.62 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $60.82 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $47.70 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Genetic Disease | ||||||
| 06/15/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Genetic Disease | ||||||
| 06/14/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Travel and Lodging | In-kind items and services | $612.96 | General |
| Category: Genetic Disease | ||||||
| 06/14/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Travel and Lodging | In-kind items and services | $254.00 | General |
| Category: Genetic Disease | ||||||
| 06/14/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Travel and Lodging | In-kind items and services | $215.46 | General |
| Category: Genetic Disease | ||||||
| 03/21/2022 | Biogen, Inc. | SPINRAZA (Biological) | Travel and Lodging | In-kind items and services | $135.00 | General |
| Category: Neurology | ||||||
| 03/15/2022 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 03/14/2022 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $72.61 | General |
| Category: Neurology | ||||||
| 11/23/2021 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $75.00 | General |
| 03/17/2021 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $49.49 | General |
| Category: NEUROLOGY | ||||||
| 02/12/2021 | Novartis Gene Therapies, Inc. (fka AveXis, Inc.) | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $60.00 | General |
| 12/17/2020 | Biogen, Inc. | SPINRAZA (Biological) | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| Category: NEUROLOGY | ||||||
| 01/27/2020 | PFIZER INC. | — | — | In-kind items and services | $1,400.00 | Research |
| Study: DMD AND RARE NEUROSCIENCE CLINICAL PUBLICATION PROGRAM | ||||||
| 10/24/2019 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,200.00 | General |
| 07/20/2019 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: DMD | ||||||
| 07/20/2019 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Travel and Lodging | In-kind items and services | $484.60 | General |
| Category: DMD | ||||||
| 07/20/2019 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: DMD | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DMD AND RARE NEUROSCIENCE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,400 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 53 | 70 | $38,250 | $5,676 |
| 2022 | 2 | 47 | 53 | $25,324 | $4,589 |
| 2021 | 2 | 42 | 44 | $18,076 | $3,557 |
| 2020 | 2 | 38 | 41 | $16,109 | $2,881 |
Total Patients
180
Total Services
208
Medicare Billing
$16,703
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 54 | $30,834 | $4,571 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 16 | $7,416 | $1,105 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 25 | $11,400 | $2,077 | 18.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $7,344 | $1,536 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 16 | $6,580 | $975.05 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 30 | $13,680 | $2,699 | 19.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 14 | $4,396 | $857.32 | 19.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 24 | $10,843 | $2,036 | 18.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 17 | $5,266 | $845.10 | 16.0% |
About Dr. Peter Karachunski, MD
Dr. Peter Karachunski, MD is a Child & Adolescent Psychiatry healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720176308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Karachunski, MD has received a total of $29,722 in payments from pharmaceutical and medical device companies, with $12,429 received in 2024. These payments were reported across 51 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($18,515).
As a Medicare-enrolled provider, Karachunski has provided services to 180 Medicare beneficiaries, totaling 208 services with total Medicare billing of $16,703. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Minneapolis, MN
- Active Since 10/10/2006
- Last Updated 10/04/2017
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1720176308
Products in Payments
- Elevidys (Drug) $12,429
- Emflaza (Drug) $5,663
- EMFLAZA (Drug) $3,189
- SPINRAZA (Biological) $1,697
- EXONDYS 51 (Drug) $992.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Child & Adolescent Psychiatry Doctors in Minneapolis
Todd Eisenberg, M.d, M.D
Child & Adolescent Psychiatry — Payments: $2,300
Child & Adolescent Psychiatry $2,300
Dr. Taimur Malik, Md, Mph, MD, MPH
Child & Adolescent Psychiatry — Payments: $1,480
Child & Adolescent Psychiatry $1,480
Erin Myers, Md, MD
Child & Adolescent Psychiatry — Payments: $137.58
Child & Adolescent Psychiatry $137.58
Jonathan Jensen, Md, MD
Child & Adolescent Psychiatry — Payments: $65.10
Child & Adolescent Psychiatry $65.10
Suzy Peterson, Do, DO
Child & Adolescent Psychiatry — Payments: $52.23
Child & Adolescent Psychiatry $52.23
Phillip Edwardson, M.d, M.D
Child & Adolescent Psychiatry — Payments: $12.72
Child & Adolescent Psychiatry $12.72